Ivar Bleumer
Impact in
-
- Renal cell carcinoma treatment
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 6
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Renal cell carcinoma treatment 5
- Co-authors
- Egbert Oosterwijk (8 shared papers)Peter F.A. Mulders (9 shared papers)Pieter De Mulder (1 shared paper)Jeannette C. Oosterwijk‐Wakka (4 shared papers)Carola Mala (3 shared papers)Joachim Beck (3 shared papers)S. W. Melchior (3 shared papers)Maureen Völler (2 shared papers)
- Journals
- The Journal of Urology (3 papers)Journal of Immunotherapy (2 papers)British Journal of Cancer (1 paper)European Urology (1 paper)International Journal of Impotence Research (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Ivar Bleumer
11 papers receiving 549 citations
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 237
- Cancer Research 99
- Immunology 142
- Oncology 171
- Molecular Biology 256
Countries citing papers authored by Ivar Bleumer
This map shows the geographic impact of Ivar Bleumer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivar Bleumer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivar Bleumer more than expected).
Fields of papers citing papers by Ivar Bleumer
This network shows the impact of papers produced by Ivar Bleumer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivar Bleumer. The network helps show where Ivar Bleumer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivar Bleumer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 143 | |
| 2 | 2003 | 106 | |
| 3 | 2002 | 79 | |
| 4 | 2005 | 75 | |
| 5 | 2003 | 61 | |
| 6 | 2006 | 44 | |
| 7 | 2001 | 19 | |
| 8 | 2004 | 14 | |
| 9 | 2003 | 12 | |
| 10 | 2006 | 6 | |
| 11 | The role of adjuvant therapy in non-metastatic RCC. | 2006 | 4 |
| 12 | 2022 | 0 | |
| 13 | 2025 | 0 |
About Ivar Bleumer
Ivar Bleumer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Surgery, having authored 13 papers that have together received 563 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Renal and related cancers (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Multiple and Secondary Primary Cancers (1 paper), Cancer Genomics and Diagnostics (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (237 citations), Cancer Research (99 citations), Immunology (142 citations), Oncology (171 citations) and Molecular Biology (256 citations). Ivar Bleumer has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Egbert Oosterwijk, Peter F.A. Mulders, Pieter De Mulder, Jeannette C. Oosterwijk‐Wakka, Carola Mala, Joachim Beck, S. W. Melchior, Maureen Völler, Dorien M. Tiemessen and Wim H.J. Kruit. Their work appears in journals such as The Journal of Urology, Journal of Immunotherapy, British Journal of Cancer, European Urology and International Journal of Impotence Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.